Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04511546
Other study ID # 001
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 27, 2020
Est. completion date March 5, 2021

Study information

Verified date March 2021
Source Positrigo AG
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The "BPET prototype" is a small aperture PET scanner. The BPET prototype will be used with patients, which have just finished their regularly scheduled PET examination on a clinical whole body PET system. The radioactive tracer used for this procedure will still be active. This remaining acitivity will be used for an image acquisition with the BPET prototype without the need for an additional radioactive tracer dose. The control intervention is be a brain PET scan as part of standard clinical routine. It will be done immediately before the scan on the BPET prototype.


Recruitment information / eligibility

Status Completed
Enrollment 10
Est. completion date March 5, 2021
Est. primary completion date March 5, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - Capable of giving Informed Consent as documented by signature (Appendix Informed Consent Form) - ability to sit still in the head-only PET scanner for 15 minutes - Are scheduled to receive a regular brain PET scan as part of clinical routine. - Male and Female patients 18 years to 80 years of age Exclusion Criteria: - Contraindications to PET examination, - Patient height smaller than 160 cm or taller than 200 cm, - Patient weight more than 120 kg, - Patient cannot sit upright for at least 15 minutes, - Metal implants in the head, - Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, severe dementia, etc. of the participant, - Participation in another study with investigational drug/device within the 30 days preceding and during the present study, - Previous enrolment into the current study, - Enrolment of the investigator, his/her family members, employees and other dependent persons.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
BPET Prototype Scan
Scan on the BPET Prototype PET system and qualitative comparison with a PET image acquired on a conventional clinical PET system.

Locations

Country Name City State
Switzerland PET Center Schlieren Schlieren ZH

Sponsors (2)

Lead Sponsor Collaborator
Positrigo AG University of Zurich

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Other Assessment of adverse events Safety of the procedure will be assessed by documenting adverse events (description of the adverse events, number of participants) During the imaging procedure which should last 15 minutes.
Other Assessment of device deficiencies Safety of the procedure will be assessed by documenting device deficiencies (description of the deficiency). During the imaging procedure which should last 15 minutes.
Other Identification of new risks Safety of the procedure will be assessed by identifying and documenting any new risk. During the imaging procedure which should last 15 minutes.
Primary PET image of the brain The primary outcome will be a PET image of the brain for each participant taken on BPET. It will be compared against the image taken by the conventional PET machine by a trained physician and judged by whether it could be used for diagnosis and further analysis. 1 day
Secondary Usability (patient feedback for seat comfort) The secondary outcome with respect to usability will be feedback from patients with respect to patient seat comfort. 1 day
Secondary Usability (medical technologist feedback for ease of positioning) The secondary outcome with respect to usability will be feedback from medical technologist with respect to easiness of patient positioning. 1 day
See also
  Status Clinical Trial Phase
Recruiting NCT05378035 - DOAC in Chinese Patients With Atrial Fibrillation
Completed NCT05080777 - Pilot Pragmatic Clinical Trial to Embed Tele-Savvy Into Health Care Systems N/A
Recruiting NCT06186024 - A PROSPECTIVE, MULTICENTER, SINGLE-ARM TRIAL FOR THE NEW SIZES OF BRIDGE STENTS FOR VERTEBRAL ARTERY STENOSIS: Bridge-MAX N/A
Completed NCT06073145 - Transcranial Doppler Using Wearable Ultrasound Patch
Completed NCT03295786 - Clinical Study to Test the Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease Phase 1/Phase 2
Recruiting NCT06010823 - Safety and Efficacy Evaluation of the Robotic Enhanced Error Training of Upper Limb Function in Post-stroke and Post TBI Participants N/A
Completed NCT01915368 - Determining Optimal Post-Stroke Exercise (DOSE) N/A
Completed NCT02889939 - High-intensity Training in an Enriched Environment in Late Phase After Stroke N/A
Recruiting NCT05443542 - VIrtual Reality in Cognitive Rehabilitation of Processing Speed for Persons With ABI N/A
Active, not recruiting NCT03911388 - HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors Phase 1
Completed NCT03994822 - pRESET for Occlusive Stroke Treatment N/A
Recruiting NCT06189950 - Registration Trial of the Intracranial Visualized Stent for the Wide-necked Intracranial Aneurysms:REBRIDGE N/A
Completed NCT04283253 - Predictors of Response in Chronic Stroke N/A
Recruiting NCT05578300 - Effective Translation of Endovascular Thrombectomy Trials Into Real-world Practice in the Asia-Pacific
Completed NCT05815836 - Precision Medicine in Stroke
Completed NCT02776189 - Dexmedetomidine Verses Propofol for Paediatric MRI Brain Phase 4
Completed NCT00829361 - Stroke Telemedicine for Arizona Rural Residents Trial N/A
Recruiting NCT03678194 - Treating Depression on a Day-to-day Basis: Development of a Tool for Physicians Based on a Smartphone Application N/A
Recruiting NCT05048680 - Effect of Hypoxic Conditioning on Cerebrovascular Health in the Elderly N/A
Recruiting NCT04742920 - The Onyx™ Trial For The Embolization Of The Middle Meningeal Artery For Chronic Subdural Hematoma (OTEMACS) N/A